Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Tesamorelin

Growth Hormone-Releasing Hormone (1-44) amide

Tesamorelin is an FDA-approved synthetic growth hormone-releasing hormone (GHRH) analog specifically indicated for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy. It works by stimulating the pituitary gland to release growth hormone, leading to targeted reduction in visceral adipose tissue through enhanced lipolysis and fat metabolism.

Complete Dosing Guide

Quick Reference

2mg
Typical Dose
Variable
Frequency
26-38
Half-Life
SubQ
Route

Administration Method

Daily subcutaneous injection in abdominal area on empty stomach

Step-by-Step Dosing Protocol

Week 1-2
2mg daily
Standard therapeutic dose establishment
Evening injection on empty stomach, 30 minutes before food or 2 hours after eating
Week 3-12
2mg daily
Initial treatment phase monitoring
Continue evening timing, monitor injection site rotation, assess glucose levels weekly
Week 13-26
2mg daily
Primary efficacy evaluation period
Assess visceral fat reduction via imaging, monitor IGF-1 levels monthly
Week 27+
2mg daily
Long-term maintenance therapy
Sustained treatment needed to maintain benefits, discontinuation leads to fat redistribution return

Dosage Calculator

Dose Calculator

Peptide amount must be greater than 0

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Tesamorelin (Egrifta) is an FDA-approved prescription medication that should only be used under the supervision of a qualified healthcare provider. Treatment requires proper patient selection, monitoring, and management of potential side effects. Patients must be evaluated for contraindications including active malignancy and diabetic complications. Regular monitoring of glucose levels, IGF-1, and treatment response is essential for safe and effective use.